Loading organizations...
§ Private Profile · San Francisco, CA, USA
App for managing care of autistic students
Nightingale has raised $6.7M across 2 funding rounds.
Key people at Nightingale.
Nightingale was founded in 2013 by Delian Asparouhov (Founder/CEO).
Nightingale has raised $6.7M in total across 2 funding rounds.
Nightingale is the clinical decision support solution for evidence-based interventions. We're committed to ensuring that service providers for individuals with autism and related disorders are equipped to administer high quality, personalized treatment.
According to the CDC, 1 in 68 children in the U.S. are now diagnosed with autism, contributing to an estimated 1.5 million Americans living with the condition. Although autism has no known cure or scientifically proven pharmaceutical treatment, its symptoms can be abated and maintained through rigorous evidence-based interventions like applied behavior analysis, speech-language pathology, and occupational therapy.
Nightingale provides these practitioners with a suite of tools for HIPAA-compliant data collection,reporting, and analytics that can be customized to any curriculum and used in any setting. By equipping service providers with a convenient and user-friendly solution for data management and analytics, Nightingale frees up more of their time for creating high-quality curriculums and working with clients.
Nightingale has raised $6.7M across 2 funding rounds. Most recently, it raised $6.0M Nightingale Security - Series A in December 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2017 | $6M Series A | — | Accelerator Ventures, Craft Ventures, Matt Mazzeo | Announced |
| Mar 1, 2015 | $660K Seed | — | Asylum Ventures, Digital Currency Group, Haun Ventures, Khosla Ventures, OAK HC/FT, RRE Ventures, Spring Capital, Scott Banister | Announced |
Nightingale was founded in 2013 by Delian Asparouhov (Founder/CEO).
Nightingale has raised $6.7M in total across 2 funding rounds.
Nightingale's investors include Accelerator Ventures, Craft Ventures, Matt Mazzeo, Asylum Ventures, Digital Currency Group, Haun Ventures, Khosla Ventures, Oak HC/FT, RRE Ventures, Spring Capital, Scott Banister.
Key people at Nightingale.
Nightingale is an app designed to manage the care of autistic students by providing clinical decision support for evidence-based interventions. It equips service providers—such as therapists and educators working with individuals with autism—with HIPAA-compliant tools for data collection, reporting, and analytics that can be customized to any curriculum and setting. This enables practitioners to deliver personalized, high-quality treatment more efficiently, addressing the needs of an estimated 1.5 million Americans living with autism. Nightingale’s mission centers on improving the quality and accessibility of autism therapy through technology, focusing on health-tech and education sectors. Although the original Nightingale app is currently inactive, it played a role in advancing digital tools for autism care[1][5].
Nightingale was founded by Delian Asparouhov and participated in Y Combinator’s Summer 2014 batch. The idea emerged from the need to support therapists and caregivers in schools and homes to better track and manage behavioral health data for autistic children. Early traction included recognition from accelerator programs like Y Combinator and StartX, and the launch of a support platform aimed at clinicians to improve autism therapy quality. The company was based in San Francisco and focused on creating a user-friendly, customizable solution for evidence-based autism interventions[1][2][5].
Nightingale rides the growing trend of digital health solutions aimed at improving care for neurodiverse populations, particularly autism spectrum disorder (ASD). The timing aligns with increasing autism diagnoses and a rising demand for scalable, evidence-based therapeutic tools. Market forces such as the push for personalized medicine, data-driven clinical decision-making, and telehealth adoption favor platforms like Nightingale. By focusing on autism therapy, Nightingale contributes to the broader ecosystem of health-tech innovations that enhance clinical workflows and patient outcomes in specialized care domains[1][5][6].
While Nightingale’s original app is currently inactive, its early work highlights the critical need for digital tools in autism care management. Future opportunities lie in integrating more advanced analytics, AI-driven personalization, and expanding interoperability with educational and healthcare systems. Trends such as increased teletherapy, remote monitoring, and data-driven behavioral health interventions will shape the evolution of platforms like Nightingale. Continued innovation in this space could significantly influence how care providers deliver personalized, evidence-based autism therapies at scale.
---
*Note:* There is a separate entity called Nightingale Apps LLC focused on nursing workflow tools, founded by Tiffany Kelley, which is distinct from the Nightingale autism care app founded by Delian Asparouhov[4][7]. This summary pertains specifically to the Nightingale app for managing care of autistic students.
